[
    [
        {
            "time": "2018-07-27",
            "original_text": "Health Care Sector Update for 07/27/2018: SGEN,NBRV,ABBV,TNXP",
            "features": {
                "keywords": [
                    "Health Care Sector",
                    "Update",
                    "SGEN",
                    "NBRV",
                    "ABBV",
                    "TNXP"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Health Care Sector Update for 07/27/2018: SGEN,NBRV,ABBV,TNXP",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        },
        {
            "time": "2018-07-27",
            "original_text": "US STOCKS-Tech, healthcare stocks weigh on Wall Street",
            "features": {
                "keywords": [
                    "US STOCKS",
                    "Tech",
                    "healthcare stocks",
                    "Wall Street"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "technology",
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "US STOCKS-Tech, healthcare stocks weigh on Wall Street",
                "Correlation": 5,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-07-27",
            "original_text": "AbbVie (ABBV) Q2 Earnings Beat Estimates, 2018 View Up",
            "features": {
                "keywords": [
                    "AbbVie",
                    "Q2",
                    "Earnings",
                    "Beat",
                    "Estimates",
                    "2018",
                    "View",
                    "Up"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "AbbVie (ABBV) Q2 Earnings Beat Estimates, 2018 View Up",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-07-27",
            "original_text": "AbbVie cash cow Humira barely beats sales estimates, stock slides",
            "features": {
                "keywords": [
                    "AbbVie",
                    "Humira",
                    "sales estimates",
                    "stock slides"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "AbbVie cash cow Humira barely beats sales estimates, stock slides",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-07-27",
            "original_text": "Pharma Stock Roundup: LLY, AGN Post Solid Q2 Results, ABBV's Elagolix Gets FDA Nod",
            "features": {
                "keywords": [
                    "Pharma Stock",
                    "LLY",
                    "AGN",
                    "Solid Q2 Results",
                    "ABBV",
                    "Elagolix",
                    "FDA Nod"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Pharma Stock Roundup: LLY, AGN Post Solid Q2 Results, ABBV's Elagolix Gets FDA Nod",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        },
        {
            "time": "2018-07-27",
            "original_text": "Roche (RHHBY) 1H18 Revenues Up Y/Y on Solid New Drug Sales",
            "features": {
                "keywords": [
                    "Roche",
                    "1H18",
                    "Revenues",
                    "Up",
                    "Y/Y",
                    "New Drug Sales"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Roche (RHHBY) 1H18 Revenues Up Y/Y on Solid New Drug Sales",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        },
        {
            "time": "2018-07-27",
            "original_text": "AbbVie Reports Second-Quarter 2018 Financial Results",
            "features": {
                "keywords": [
                    "AbbVie",
                    "Second-Quarter",
                    "2018",
                    "Financial Results"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "AbbVie Reports Second-Quarter 2018 Financial Results",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 10,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        }
    ]
]